TODAY show contributor Jill Martin opened up about her recent breast cancer diagnosis, and urged viewers to speak with their doctors to see if genetic testing is warranted. Says Martin, … Continued
Snap summary: OCRA-funded researchers set out to improve immune response against a known therapeutic target, and provided a glimpse into a world where an ovarian cancer patient’s own immune system … Continued
Janice Paulshock first began connecting with others in the ovarian cancer community in 1999 after being diagnosed with Stage 3C high-grade serous carcinoma. Twenty-plus years and four recurrences later, she … Continued
Jill McGill, reigning champion of the U.S. Senior Women’s Open, continued to champion the ovarian cancer cause at last week’s U.S. Women’s Open at Pebble Beach, handing out special ball-markers … Continued
In a new article published in Everyday Health, experts spoke about the disparities Black Americans face when diagnosed with ovarian cancer, exploring reasons why these disparities may exist, and offering … Continued
Update to Clinical Guidelines: Special Circumstance Chemotherapy Approvals Last month, we reported news of an ongoing shortage of chemotherapy drugs essential to ovarian cancer treatment. Though the shortage continues, patients … Continued
Summer is officially here! Strengthen your connection to community this season with special support offerings, interactive roundtables and summer-themed sessions for those impacted by ovarian and other gynecologic cancers. And … Continued
Share your thoughts on multi-cancer detection tests and what role they might have, or not, for ovarian cancer? OCRA’s Scientific Advisory Committee (SAC) is comprised of doctors and researchers who … Continued
Being a professional athlete takes immense focus and determination — traits that pro golfer and defending champion of the U.S. Senior Women’s Open Jill McGill is harnessing to take on … Continued
Diagnosed with ovarian cancer in 2022, Marsha Biven currently participates in a number of OCRA programs, including Staying Connected, Survivors Teaching Students, and Woman to Woman. Read on to learn … Continued
This action alert has now expired. This shortage of chemotherapy drugs, including cisplatin and carboplatin, has reached a serious level, impacting the treatment options available to some ovarian cancer patients. … Continued
What to Know About the Chemotherapy Drug Shortage As many are aware, the U.S. is currently experiencing a matter of great concern: an ongoing shortage of chemotherapy drugs that are essential … Continued
Get email updates about research news, action alerts, and ways to join the fight.
